openPR Logo
Press release

Drug Discovery Technologies Market Share and Growth Factors Impact Analysis 2017 - 2025

02-26-2018 05:05 PM CET | Health & Medicine

Press release from: Transparency Market Research - Biotechnology

Drug Discovery Technologies Market Share and Growth Factors

Global Drug Discovery Technologies Market: Overview

Due to the prevalence of several life-threatening diseases and frequent inception of new health-related issues, it is essential to discover new, advanced, efficient drugs to combat the illness. Healthcare organizations across the world are actively looking for opportunities for drug discovery, which was historically done through identification of active ingredient from traditional remedies. However, in the recent past, the field of drug discovery has evolved considerably with technologies such as mass spectrometry, NMR, micro plate readers, chemotherapy, proteomics (2DGE, two hybrid systems, isotope encoding and activity based assays), RANi (siRNA, miRNA, ddRNAi, and short hairpin RNAs), microfluidics, gel electrophoresis, protein and nucleic acid isolation, DNA and protein microarrays, and nanotechnology, which includes atomic force microscopy, nano mass spectroscopy, and dip pen nanolithography. Drug discovery process have now become more refined and accurate, as well as significantly less time consuming.

It has been observed that high-throughput screening (HTS) is one of the most widely used drug discovery technologies. Through this technology, a large number of potential biological modulators are assayed against a chosen set of defined targets. HTS technology enables building a portfolio of biologically relevant compounds quickly. Advancement in HTS technology such as reliable automation, multidetector readers, imaging hardware and software, and database and pattern recognition software will lead to the increased usage of the technology in future.

Drug discovery technologies play a major role in overall growth of the pharmaceutical industry because they significantly contribute to the easy introduction of blockbusters and innovative drugs. Diverse diseases such as cancer, CVD and CNS disorders such as Parkinson’s and Alzheimer’s have generated ample opportunities in the market for drug discovery technologies, which is estimated for a healthy growth rate during the forecast period of 2016–2024.

Get Brochure of Report @

Global Drug Discovery Technologies Market: Trends and Opportunities

The market is primarily driven by rising geriatric population across the globe as people aged over 60 years are more prone to chronic diseases. The demand for efficient drugs, especially from the rising population of affluent patients, is another factor pushing the global market for drug discovery technologies. Moreover, advances in the fields of biotechnology, molecular biology, nanotechnology, and genomics in the recent past have also paved way for increased investments in the field of drug discovery. Furthermore, patent expiries of several blockbuster drugs during the forecast period are also expected to make it a lucrative market for the existing players. New pharmaceutical companies also have an opportunity to venture into the global market for drug discovery technologies through generics.

As drug discovery plays an important role in the drug development cycle, pharmaceutical companies focus more on drug development technologies. However, drug discovery and development requires a huge investment and takes a long time, which leads to lower profit margins for the pharmaceutical companies. Pharmaceutical manufacturers usually face an impending surge of expiring patents regarding developed drugs, exacerbating the adverse effects of the long duration of the research cycle. This could hinder the market’s growth in the coming years.

Request Report For TOC @

Global Drug Discovery Technologies Market: Region-wise Outlook

Geographically, the global market for drug discovery technologies can be segmented into the regions of North America, Europe, Asia Pacific, and Rest of the World. Currently, North America is the most lucrative market due to high concentration of world’s leading pharmaceutical companies. The governments in North American countries such as the U.S. and Canada have also formulated encouraging policies for the investors to research and develop new drugs. The demand for drug discovery technologies in the region of North America also gains from high-income population, collectively promising healthy potential returns on investments due to high adoption rate of new technologies. Asia Pacific holds immense promise as a market for drug discovery technologies due to rising disposable incomes, favorable long-term government policies, and aggressive investment by pharmaceutical industry in the region, which has skilled labor at affordable cost.

Companies mentioned in the research report 

Some of the key players in the global drug discovery technologies market are Abbott Laboratories, Inc., Affymetrix Inc., Agilent Technologies, Inc., Bayer Healthcare AG, GE Healthcare Ltd., Albany Molecular Research Inc., Arqule Inc., Astrazeneca plc, Novartis AG, Luminex Corporation, and Molecular Discovery Ltd. Many of the key players are partnering to develop sophisticated drug discovery technologies and discover novel drugs for various ailments.

Get Discount on Report @

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Discovery Technologies Market Share and Growth Factors Impact Analysis 2017 - 2025 here

News-ID: 958267 • Views: 645

More Releases from Transparency Market Research - Biotechnology

Automotive Coatings Market to Reach US$ 33.63 Bn by 2026
Albany, NY - The global automotive coatings market is expected to expand at a healthy rate of 6.28% CAGR between 2018 to 2026, elucidates an upcoming report by automotive coatings market. The global automotive coatings market is likely to grow at a healthy rate in the upcoming years. The rising disposable income is paving way for the customer to look for attractive colors and they do not mind paying to improve aesthetic.
Petrochemicals Market value worth US$ 7.0 Trillion by 2027
Albany, NY - Petrochemicals Market: Introduction In terms of value, the global petrochemicals market is anticipated to expand at a CAGR of 4% from 2020 to 2030. Petrochemicals are an important part of commodities that are used in daily lives. Petrochemical products are used in various end-use industries, ranging from manufacturing to consumer goods. These chemical compounds are derived from petroleum as well as other hydrocarbons, which are obtained from natural
HIV/AIDS Diagnostics Market Is Projected to Expand at a CAGR of ~9% from 2019 to 2027
HIV/AIDS Diagnostics Market Is Projected to Expand at a CAGR of ~9% from 2019 to …
Transparency Market Research (TMR) has published a new report on the HIV/AIDS diagnostics market for the forecast period of 2019–2027. According to the report, the global HIV/AIDS diagnostics market was valued at ~US$ 3 Bn in 2018, and is projected to expand at a CAGR of ~9% from 2019 to 2027. Read Report Overview - HIV/AIDS Diagnostics: Overview HIV infection can be identified either by the detection of HIV-specific antibodies in the
Hair Loss Treatment Products Market Emerging Trends and Competitive Landscape Forecast to 2027 | Key Players include Sun Pharmaceutical Industries Ltd., Aclaris Therapeutics, Inc., Concert Pharmaceuticals
Hair Loss Treatment Products Market Emerging Trends and Competitive Landscape Fo …
Global Hair Loss Treatment Products Market: Introduction Baldness generally refers to excessive hair loss from a person’s scalp. Hereditary hair loss with age is considered to be the most common cause of baldness. Some people prefer to let their hair loss run its course unhidden and untreated. There are various causes of hair fall, and various treatments for hair fall. Hair loss treatment products prevent further hair loss and restore growth. Read

All 5 Releases

More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug